anx005
Showing 1 - 5 of 5
Amyotrophic Lateral Sclerosis Trial in Canada, United States (ANX005)
Recruiting
- Amyotrophic Lateral Sclerosis
- ANX005
-
Phoenix, Arizona
- +10 more
Jul 1, 2022
Huntington Disease Trial in United States (ANX005)
Active, not recruiting
- Huntington Disease
- ANX005
-
Birmingham, Alabama
- +5 more
Nov 19, 2021
Guillain-Barré Syndrome Trial in Dhaka, Aarhus (ANX005, Intravenous immunoglobulin)
Completed
- Guillain-Barré Syndrome
- ANX005
- Intravenous immunoglobulin
-
Dhaka, Bangladesh
- +1 more
Aug 9, 2021
Guillain-Barre Syndrome Trial in Dhaka (ANX005, Placebo)
Recruiting
- Guillain-Barre Syndrome
- ANX005
- Placebo
-
Dhaka, BangladeshNational Institute of Neurosciences and Hospital (NINS)
Jan 7, 2021
Safety and Tolerability in Healthy Volunteers Trial in Melbourne (ANX005, IVIg, Placebos)
Terminated
- Safety and Tolerability in Healthy Volunteers
- ANX005
- +2 more
-
Melbourne, Victoria, AustraliaNucleus Network
Aug 19, 2020